Anne Bruinvels: Digital health is working in oncology. Just not where many expect
Anne Bruinvels, Founder & CEO at OWise by Px HealthCare, shared a post on LinkedIn:
“Digital health is working in oncology. Just not where many expect.
At MASCC 2025 (Multinational Association of Supportive Care in Cancer), a multi-center real-world study from The Christie NHS Foundation Trust showed that remote symptom monitoring, via electronic PROMs, improved both patient satisfaction and sustained engagement in everyday cancer care.
No gimmicks. No nudges. Just thoughtful design, clinical integration, and trust.
That’s not the typical narrative around digital tools in oncology, but it’s the one that matters. And it’s what we’ve seen consistently with OWise.
The average OWise user tracks their well-being and symptoms twice a week, spending over 2 minutes each time in the app. That’s not passive usage, it’s active, consistent involvement over time. And it’s the kind of engagement that makes real-world evidence not just possible, but meaningful.
That might sound simple. But it’s not common. Most cancer apps lose users within weeks. OWise keeps people engaged across treatment and beyond. That’s what makes our data not just robust, but reproducible. Because digital health only works when people choose to keep using it. And when they do, everything from adherence to insight gets stronger.
MASCC article by OncoDaily can be found here.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023